SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
SUTRO BIOPHARMA reports 2019 executive compensation
By ExecPay News
Published: April 29, 2021
SUTRO BIOPHARMA reported fiscal year 2019 executive compensation information on April 29, 2021.
In 2019, five executives at SUTRO BIOPHARMA received on average a compensation package of $1.5M, a 73% decrease compared to previous year.
Average pay of disclosed executives at SUTRO BIOPHARMA
William J. Newell, Chief Executive Officer, received $3.8M in total, which decreased by 56% compared to 2018. 81% of Newell's compensation, or $3.1M, was in option awards. Newell also received $223K in non-equity incentive plan and $497K in salary.
Trevor Hallam, Chief Scientific Officer, received a compensation package of $1M, which decreased by 77% compared to previous year. 41% of the compensation package, or $418K, was in salary.
Arturo Molina, Chief Medical Officer, earned $947K in 2019.
Arturo Molina, M.D., M.S., FACP, Chief Medical Officer, received $947K in 2019, which decreases by 72% compared to 2018.
Linda Fitzpatrick, Chief People and Communications Officer, earned $713K in 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2021.